4-iododexetimide and Epilepsy--Temporal-Lobe

4-iododexetimide has been researched along with Epilepsy--Temporal-Lobe* in 2 studies

Other Studies

2 other study(ies) available for 4-iododexetimide and Epilepsy--Temporal-Lobe

ArticleYear
Effect of partial volume correction on muscarinic cholinergic receptor imaging with single-photon emission tomography in patients with temporal lobe epilepsy.
    European journal of nuclear medicine, 1997, Volume: 24, Issue:9

    Animal experiments and preliminary results in humans have indicated alterations of hippocampal muscarinic acetylcholine receptors (mAChR) in temporal lobe epilepsy. Patients with temporal lobe epilepsy often present with a reduction in hippocampal volume. The aim of this study was to investigate the influence of hippocampal atrophy on the quantification of mAChR with single photon emission tomography (SPET) in patients with temporal lobe epilepsy. Cerebral uptake of the muscarinic cholinergic antagonist [123I]4-iododexetimide (IDex) was investigated by SPET in patients suffering from temporal lobe epilepsy of unilateral (n=6) or predominantly unilateral (n=1) onset. Regions of interest were drawn on co-registered magnetic resonance images. Hippocampal volume was determined in these regions and was used to correct the SPET results for partial volume effects. A ratio of hippocampal IDex binding on the affected side to that on the unaffected side was used to detect changes in muscarinic cholinergic receptor density. Before partial volume correction a decrease in hippocampal IDex binding on the focus side was found in each patient. After partial volume no convincing differences remained. Our results indicate that the reduction in hippocampal IDex binding in patients with epilepsy is due to a decrease in hippocampal volume rather than to a decrease in receptor concentration.

    Topics: Adult; Atrophy; Dexetimide; Epilepsy, Temporal Lobe; Female; Hippocampus; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Receptors, Muscarinic; Tomography, Emission-Computed, Single-Photon

1997
Decreased hippocampal muscarinic cholinergic receptor binding measured by 123I-iododexetimide and single-photon emission computed tomography in epilepsy.
    Annals of neurology, 1993, Volume: 34, Issue:2

    Regional binding of 123I-iododexetimide, a muscarinic acetylcholine receptor antagonist, was measured in vivo in the temporal lobes of 4 patients with complex partial seizures using single-photon emission computed tomography. In the anterior hippocampus ipsilateral to the electrical focus, 123I-iododexetimide binding was decreased by 40 +/- 9% (mean +/- SD, p < 0.01) compared with the contralateral hippocampus; 123I-iododexetimide binding in other temporal lobe regions was symmetrical. The data indicate a regionally specific change of muscarinic acetylcholine receptor in anterior hippocampus in complex partial seizures of temporal lobe origin.

    Topics: Adult; Case-Control Studies; Dexetimide; Electroencephalography; Epilepsy, Temporal Lobe; Female; Hippocampus; Humans; Iodine Radioisotopes; Male; Middle Aged; Receptors, Muscarinic; Tomography, Emission-Computed, Single-Photon

1993